Omecamtiv Mecarbil for Heart Failure Turned Down by FDA

(MedPage Today) -- Heart failure patients won't be getting another drug on the market in the form of omecamtiv mecarbil, now that FDA rejected approval of the cardiac myosin activator. The agency thus followed the advice of its Cardiovascular...
Source: MedPage Today Nephrology - Category: Urology & Nephrology Source Type: news